mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.007 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.008 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.009 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |